Cargando...
In Vivo Selection of Respiratory Syncytial Viruses Resistant to Palivizumab
Palivizumab (PZ) is the only monoclonal antibody currently available for use in humans against an infectious disease. PZ is administered prophylactically for respiratory syncytial virus (RSV) infections. RSV selected in cell culture for growth in the presence of PZ develops F gene mutations and can...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology
2005
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1061530/ https://ncbi.nlm.nih.gov/pubmed/15767398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.7.3962-3968.2005 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|